275 related articles for article (PubMed ID: 21955647)
1. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk.
Setchell KD; Brown NM; Zhao X; Lindley SL; Heubi JE; King EC; Messina MJ
Am J Clin Nutr; 2011 Nov; 94(5):1284-94. PubMed ID: 21955647
[TBL] [Abstract][Full Text] [Related]
2. Distribution of isoflavones in samples of serum, liver and mammary glands of rats or pigs fed dietary isoflavones.
Gilani GS; Farmer C; Dyck M; Robertson P; Dahiya J; Sepehr E; Fan L; Nicolidakis H; Curran I; Cooke GM
Ann Nutr Metab; 2011; 58(3):171-80. PubMed ID: 21654164
[TBL] [Abstract][Full Text] [Related]
3. Exposure of infants to phyto-oestrogens from soy-based infant formula.
Setchell KD; Zimmer-Nechemias L; Cai J; Heubi JE
Lancet; 1997 Jul; 350(9070):23-7. PubMed ID: 9217716
[TBL] [Abstract][Full Text] [Related]
4. Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula.
Cao Y; Calafat AM; Doerge DR; Umbach DM; Bernbaum JC; Twaddle NC; Ye X; Rogan WJ
J Expo Sci Environ Epidemiol; 2009 Feb; 19(2):223-34. PubMed ID: 18665197
[TBL] [Abstract][Full Text] [Related]
5. Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults.
Gardner CD; Chatterjee LM; Franke AA
J Nutr Biochem; 2009 Mar; 20(3):227-34. PubMed ID: 18602820
[TBL] [Abstract][Full Text] [Related]
6. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.
van der Velpen V; Hollman PC; van Nielen M; Schouten EG; Mensink M; Van't Veer P; Geelen A
Eur J Clin Nutr; 2014 Oct; 68(10):1141-7. PubMed ID: 24939433
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary genistein on hormone-dependent rat mammary carcinogenesis induced by ethyl methanesulphonate.
Ono M; Koga T; Ueo H; Nakano S
Nutr Cancer; 2012; 64(8):1204-10. PubMed ID: 23163849
[TBL] [Abstract][Full Text] [Related]
8. NTP-CERHR expert panel report on the developmental toxicity of soy infant formula.
McCarver G; Bhatia J; Chambers C; Clarke R; Etzel R; Foster W; Hoyer P; Leeder JS; Peters JM; Rissman E; Rybak M; Sherman C; Toppari J; Turner K
Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):421-68. PubMed ID: 21948615
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods.
Cassidy A; Brown JE; Hawdon A; Faughnan MS; King LJ; Millward J; Zimmer-Nechemias L; Wolfe B; Setchell KD
J Nutr; 2006 Jan; 136(1):45-51. PubMed ID: 16365057
[TBL] [Abstract][Full Text] [Related]
10. Disposition of soy isoflavones in normal human breast tissue.
Bolca S; Urpi-Sarda M; Blondeel P; Roche N; Vanhaecke L; Possemiers S; Al-Maharik N; Botting N; De Keukeleire D; Bracke M; Heyerick A; Manach C; Depypere H
Am J Clin Nutr; 2010 Apr; 91(4):976-84. PubMed ID: 20164315
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones increase latency of spontaneous mammary tumors in mice.
Jin Z; MacDonald RS
J Nutr; 2002 Oct; 132(10):3186-90. PubMed ID: 12368416
[TBL] [Abstract][Full Text] [Related]
12. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life.
Setchell KD; Zimmer-Nechemias L; Cai J; Heubi JE
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1453S-1461S. PubMed ID: 9848516
[TBL] [Abstract][Full Text] [Related]
13. Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County.
Wu AH; Yu MC; Tseng CC; Twaddle NC; Doerge DR
Carcinogenesis; 2004 Jan; 25(1):77-81. PubMed ID: 14555615
[TBL] [Abstract][Full Text] [Related]
14. Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women.
Nhan S; Anderson KE; Nagamani M; Grady JJ; Lu LJ
Nutr Cancer; 2005; 53(1):73-81. PubMed ID: 16351509
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones.
Ohta T; Nakatsugi S; Watanabe K; Kawamori T; Ishikawa F; Morotomi M; Sugie S; Toda T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 May; 21(5):937-41. PubMed ID: 10783315
[TBL] [Abstract][Full Text] [Related]
16. Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol.
Brown NM; Belles CA; Lindley SL; Zimmer-Nechemias L; Witte DP; Kim MO; Setchell KD
Food Chem Toxicol; 2010 Nov; 48(11):3042-50. PubMed ID: 20691242
[TBL] [Abstract][Full Text] [Related]
17. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer.
Messina M; Hilakivi-Clarke L
Nutr Cancer; 2009; 61(6):792-8. PubMed ID: 20155618
[TBL] [Abstract][Full Text] [Related]
18. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats.
Lamartiniere CA; Wang J; Smith-Johnson M; Eltoum IE
Toxicol Sci; 2002 Feb; 65(2):228-38. PubMed ID: 11812927
[TBL] [Abstract][Full Text] [Related]
19. Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults.
Frankenfeld CL; Patterson RE; Kalhorn TF; Skor HE; Howald WN; Lampe JW
J Am Diet Assoc; 2002 Oct; 102(10):1407-13. PubMed ID: 12396157
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on the soy-breast cancer relation.
Messina M; Wu AH
Am J Clin Nutr; 2009 May; 89(5):1673S-1679S. PubMed ID: 19339397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
